AstraZeneca- Oxford COVID-19 vaccine 79% effective in US trial
22 Mar 2021
AstraZeneca and Oxford University’s COVID-19 vaccine was 79% effective in a large US trial at preventing symptomatic illness, and was 100% effective against severe or critical disease and hospitalisation, the...